A study to evaluate the effectiveness of valsartan 320mg in combination with lisinopril 20mg versus monotherapy with lisinopril 40mg or valsartan 320mg in hypertensive patients with microalbuminuria on the reduction of urinary albumin creatinine ratio
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Valsartan (Primary) ; Lisinopril
- Indications Essential hypertension; Hypertension
- Focus Pharmacodynamics
- Acronyms VALERIA
- Sponsors Novartis
- 16 Nov 2011 Actual patient number is 134 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 01 Sep 2008 Primary endpoint 'Urinary albumin:creatinine ratio' has been met. Results published in the Journal of Hypertension